<Record>
<Term>Refractory Anemia</Term>
<SemanticType>Disease or Syndrome</SemanticType>
<SemanticType>Neoplastic Process</SemanticType>
<ParentTerm>NCIThesaurus</ParentTerm>
<ParentTerm>Anemia</ParentTerm>
<ParentTerm>Myelodysplastic Syndromes</ParentTerm>
<ClassificationPath>Refractory Anemia</ClassificationPath>
<ClassificationPath>Hemic and Lymphatic Diseases/Hematologic Diseases/Anemia/Anemia, Refractory</ClassificationPath>
<ClassificationPath>Hemic and Lymphatic Diseases/Hematologic Diseases/Bone Marrow Diseases/Myelodysplastic Syndromes/Anemia, Refractory</ClassificationPath>
<BroaderTerm>Refractory Anemia</BroaderTerm>
<BroaderTerm>Bone Marrow Diseases</BroaderTerm>
<BroaderTerm>Hemic and Lymphatic Diseases</BroaderTerm>
<BroaderTerm>Anemia</BroaderTerm>
<BroaderTerm>Anemia, Refractory</BroaderTerm>
<BroaderTerm>Myelodysplastic Syndromes</BroaderTerm>
<BroaderTerm>Hematologic Diseases</BroaderTerm>
<ChildTerm>Anemia, Refractory, with Excess of Blasts</ChildTerm>
<Synonym>Refractory Anemia</Synonym>
<Synonym>Refractory Anemias</Synonym>
<Synonym>Aregenerative Anemia</Synonym>
<Description>A severe sometimes chronic anemia, usually macrocytic in type, that does not respond to ordinary antianemic therapy.</Description>
<Description>A myelodysplastic syndrome characterized mainly by dysplasia of the erythroid series.  Refractory anemia is uncommon.  It is primarily a disease of older adults.  The median survival exceeds 5 years.  (WHO, 2001)</Description>
<Source>NCI Thesaurus</Source>
<Source>MeSH</Source>
</Record>
